Request for Proposal (RFP) to Tender for Purchasing Laboratory Equipment to Support Surveillance Activities in the Democratic P
Request for Proposal (RFP) to Tender for Purchasing Laboratory Equipment to Support Surveillance Activities in the Democratic People’s Republic of Korea
The International Vaccine Institute (IVI) (http://www.ivi.int) is a non-profit, international organization located in Seoul, Korea. IVI and the Academy of Medical Sciences (AMS) of the Democratic People’s Republic of Korea (DPRK) have been collaborating to improve the health of children in the Democratic People’s Republic of Korea (DPRK) since 2006.
IVI/AMS are currently collaborating to set up a surveillance system for acute encephalitis syndrome (AES) and diarrheal diseases caused by selected bacterial and viral pathogens (rotavirus, Vibrio cholerae, Campylobacter and Shigella species) through health care system capacity-building and training of DPRK scientists in collaboration with AMS and the Ministry of Public Health. To ensure successful implementation of the surveillance system in the DPRK, there is a need to provide laboratory and equipment (Appendix 2) to the Institute of Microbiology (IMB) as well as to laboratories at the surveillance hospitals. To ensure transparency of the purchasing process, IVI is opening a tendering process with different companies to purchase these laboratory and equipment which will be utilized for disease surveillance purposes within the DPRK.
The purpose of this Request for Proposal (RFP) is to advertise a tender for purchasing laboratory equipment which will be used for disease surveillance activities in the DPRK. A bidder will be selected by IVI through a competitive process to manage the procurement of laboratory equipment outside of Korea and shipment of these items to IVI’s collaborating institution (AMS) in the DPRK. Potential providers of these items are requested to describe how they intend to meet the requirements set out by IVI. A Bids and Award Committee of IVI staff will analyze each proposal and ultimately select the successful bidder.
The duration of the selection process is from June 24, 2013 to July 31, 2013, and follows IVI’s tendering regulations. Plans for money transfer will be developed in accordance with the timetable that will be discussed and agreed upon with the successful bidder.
d. Point of contact.
All applicants wishing to tender for this contract can fill out the application form enclosed as Appendices. Scientific and project-related questions can be directed to Dr. Florian Marks (email@example.com), and administrative and procedural questions can be directed to Ms. Seonwoo Yoon (firstname.lastname@example.org).
e. Structure of request for proposal
Information for this RFP is organized as follows:
- Section 2 contains the explanation of the selection process, indication of milestones, and definitions of conditions and criteria.
- Appendices include the application form and the line listing of required laboratory equipment.
2. Selection process
final contract between the IVI and the successful bidder shall be realized by July 15, 2013. Afterwards, funds are remitted to the successful bidding company and procurement of equipment can commence. Current planning and timetable of the developed activities are shown below:
|Tender open date||24 June 2013|
|Request for further information open date||03 July 2013|
|Tender closing date||19 July 2013|
|Final selection||25 July 2013|
|Negotiation with successful applicant begins||26 July 2013|
|Contract signed||31 July 2013|
b. Procedure for responses
All interested bidders should complete the application form of the RFP (enclosed in the Appendices) and return it by post/DHL by July 19, 2013 to the following person:
Ms. Seonwoo Yoon
Secretary Bids and Awards Committee
International Vaccine Institute
Tel: 82 2 8811240
Fax: 82 2 881 1211
The following conditions apply to this selection process:
- A bidder can be excluded from the selection process without any consequences.
- Effort and time spent in replying to this RFP document by the bidder cannot be charged to IVI.
- IVI may decide to terminate the tender process at any stage, which will be announced through IVI’s website.
- All bids must be submitted in English.
- IVI has the right to negotiate the contract details with short-listed bidder.
- The bidder must be able to procure items to Sinyizu (DAF Sinyizu, Incoterms 2000)
- The submitted bid documents will not be returned to the bidders.
- Evaluation and selection of the successful bidder will be made according to the IVI’s evaluation criteria and the evaluation result will not be opened to the public.
d. Items to be procured
In the course of the establishment of surveillance for acute encephalitis syndrome (AES) and diarrheal diseases, IVI will provide to IMB and laboratories at the hospitals necessary laboratory equipment. The bidder is required to purchase the equipment as specified in Appendix 2, ship it to the Sinyizu, DPR Korea (DAF Sinyizu) according to a pre-determined timeline..